Eli Lilly Digital Transformation Strategy Analysis Report 2025: Accelerators, Innovation Programs, Technology Initiatives, ICT, Partnerships, Investments & Acquisitions, Network Map

(MENAFN- GlobeNewsWire - Nasdaq) Eli Lilly's main market opportunities include expanding its pharmaceutical reach in cardiometabolic, oncology, immunology, and neuroscience sectors. Leveraging its global manufacturing and distribution network, the company can capitalize on digital transformation and innovation programs to enhance operational efficiency and product development.

Dublin, April 09, 2026 (GLOBE NEWSWIRE) -- The "Enterprise Tech Ecosystem Series: Eli Lilly - 2025" company profile has been added to ResearchAndMarkets's offering.

The report provides insights into the company's tech activities, including its digital transformation strategies, its innovation programs, its technology initiatives, and its investments.

Elli Lilly and Company (Eli Lilly) is an American pharmaceutical company engaged in the discovery, development, manufacturing, and marketing of pharmaceutical products.

The company manufactures and distributes products for cardiometabolic health, oncology, immunology, and neuroscience. Eli Lilly has drug manufacturing facilities in the US, Asia, and Europe, and it sells its products in over 95 countries.

The company holds patents for hundreds of branded drugs, including Jardiance, Mounjaro/ Zepbound, Trulicity, Cyramza, Jaypirca, Retevmo, Verzenio, Olumiant, Ebglyss, Taltz, and Omvoh, among others. The company has only one business segment: human pharmaceutical products.
The report provides information and insights into Eli Lilly's tech activities, including:

• Insights of its digital transformation strategies and innovation programs.
• Overview of technology initiatives covering partnerships, product launches, and investments.
• Insights on each technology initiative including technology theme, objective, and benefits.
• Details of estimated ICT budgets.

Reasons to Buy

• Gain insights into Eli Lilly's tech operations.
• Gain insights into its tech strategies and innovation initiatives.
• Gain insights into its technology themes under focus.
• Gain insights into various product launches, partnerships, and investments

Key Topics Covered:

• Eli Lilly's Overview
• Eli Lilly's Digital Transformation Strategy
• Eli Lilly's Accelerators, Incubators, and other Innovation Programs
• Eli Lilly's Technology Focus
• Eli Lilly's Technology Initiatives
• Eli Lilly's Tech Investments
• Eli Lilly's Tech Ecosystem
• Eli Lilly's ICT Budget
• Eli Lilly's Senior Management
• Eli Lilly's Thematic Scorecard

Companies Featured

• Creyon Bio
• BigHat Biosciences
• Welldoc
• Superluminal Medicines
• OpenAI
• Isomorphic Labs
• insitro
• Genetic Leap
• XtalPi
• Yseop
• Verge Genomics
• Tredence
• JD Health
• Amazon Pharmacy
• Strateos
• Salesforce
• HiveMQ
• Persist AI

For more information about this company profile visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN09042026004107003653ID1110963244